Market Overview

Olivier Bohuon Elected to LEO Pharma's Board of Directors


LEO Pharma expands its Board of Directors with Olivier Bohuon who
will join as vice chairman. With extensive experience in global
pharmaceuticals and medical technology, Bohuon will contribute
significantly to realising LEO Pharma's strategy of being a global
leader in medical dermatology.

This press release features multimedia. View the full release here:

Olivier Bohuon elected to LEO Pharma's Board of Directors (Photo: Business Wire)

Olivier Bohuon elected to LEO Pharma's Board of Directors (Photo: Business Wire)

On August 27th an extraordinary general meeting elected
Olivier Bohuon as a new member of LEO Pharma's Board of Directors. He
will serve as the Board of Directors' new vice chairman.

"I am excited to welcome Olivier Bohuon to LEO Pharma's Board of
Directors," said Jukka Pertola, Chairman of LEO Pharma's Board of
Directors. "Olivier brings extensive strategic and commercial expertise
in the global pharma industry. This will benefit LEO Pharma greatly as
we are expanding into new innovative treatments in our ambition of being
a global leader in medical dermatology," Pertola continued.

"LEO Pharma is a company with a very strong vision. Its focus area of
medical dermatology is strongly growing, highly competitive and
benefiting from scientific advances in biotechnology. I am delighted to
be able to help LEO Pharma succeed with its ambitious strategy," said
Olivier Bohuon.

Olivier Bohuon brings extensive experience in the global pharmaceutical
and med-tech industry. He is board member of Smiths Group plc, senior
independent director at Shire plc, supervisory board member at Virbac
SA, and member of the National Pharmacy Academy and the Academy of
Technologies. From 2011 to May 2018 Bohuon served as CEO of medical
equipment specialist Smith & Nephew plc. Before that, he held positions
as CEO at Laboratories Pierre Fabre, EVP, pharmaceutical products at
Abbott Laboratories and SVP, director of European Commercial Operations
at GlaxoSmithKline.

- ENDS -

About LEO Pharma

LEO Pharma helps people achieve healthy skin. By offering care solutions
to patients in more than 130 countries globally, LEO Pharma supports
people in managing their skin conditions. Founded in 1908 and owned by
the LEO Foundation, the healthcare company has devoted decades of
research and development to delivering products and solutions to people
with skin conditions. LEO Pharma is headquartered in Denmark and employs
around 5,200 people worldwide.

For more information, visit

Subscribe to our YouTube channel:

Follow us on Twitter:

Visit us at LinkedIn:

View Comments and Join the Discussion!